Standard
Rates of cardiovascular disease following smoking cessation in patients with HIV infection : results from the D:A:D study(*). / Petoumenos, K; Worm, S; Reiss, P; de Wit, S; d'Arminio Monforte, A; Sabin, C; Friis-Møller, N; Weber, R; Mercie, P; Pradier, C; El-Sadr, W; Kirk, O; Lundgren, J; Law, Mg; D:A:D Study Group.
I:
Topics in HIV Medicine, Bind 12, Nr. 7, 2011, s. 412-21.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Petoumenos, K, Worm, S, Reiss, P, de Wit, S, d'Arminio Monforte, A, Sabin, C, Friis-Møller, N, Weber, R, Mercie, P, Pradier, C, El-Sadr, W
, Kirk, O, Lundgren, J, Law, M & D:A:D Study Group 2011, '
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*)',
Topics in HIV Medicine, bind 12, nr. 7, s. 412-21.
https://doi.org/10.1111/j.1468-1293.2010.00901.x,
https://doi.org/10.1111/j.1468-1293.2010.00901.xAPA
Petoumenos, K., Worm, S., Reiss, P., de Wit, S., d'Arminio Monforte, A., Sabin, C., Friis-Møller, N., Weber, R., Mercie, P., Pradier, C., El-Sadr, W.
, Kirk, O., Lundgren, J., Law, M., & D:A:D Study Group (2011).
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*).
Topics in HIV Medicine,
12(7), 412-21.
https://doi.org/10.1111/j.1468-1293.2010.00901.x,
https://doi.org/10.1111/j.1468-1293.2010.00901.xVancouver
Author
Petoumenos, K ; Worm, S ; Reiss, P ; de Wit, S ; d'Arminio Monforte, A ; Sabin, C ; Friis-Møller, N ; Weber, R ; Mercie, P ; Pradier, C ; El-Sadr, W ; Kirk, O ; Lundgren, J ; Law, Mg ; D:A:D Study Group. / Rates of cardiovascular disease following smoking cessation in patients with HIV infection : results from the D:A:D study(*). I: Topics in HIV Medicine. 2011 ; Bind 12, Nr. 7. s. 412-21.
Bibtex
@article{28d4763b6e4a4a91a446b8e15ded9b1b,
title = "Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*)",
abstract = "The aim of the study was to estimate the rates of cardiovascular disease (CVD) events after stopping smoking in patients with HIV infection.",
keywords = "Adult, Argentina, CD4 Lymphocyte Count, Cardiovascular Diseases, Cohort Studies, Europe, Female, HIV Infections, Humans, Incidence, Male, Middle Aged, Prospective Studies, Risk Factors, Smoking, Smoking Cessation, United States",
author = "K Petoumenos and S Worm and P Reiss and {de Wit}, S and {d'Arminio Monforte}, A and C Sabin and N Friis-M{\o}ller and R Weber and P Mercie and C Pradier and W El-Sadr and O Kirk and J Lundgren and Mg Law and {D:A:D Study Group}",
note = "{\textcopyright} 2011 British HIV Association.",
year = "2011",
doi = "10.1111/j.1468-1293.2010.00901.x",
language = "English",
volume = "12",
pages = "412--21",
journal = "Topics in antiviral medicine",
issn = "2161-5861",
publisher = "International AIDS Society - USA",
number = "7",
}
RIS
TY - JOUR
T1 - Rates of cardiovascular disease following smoking cessation in patients with HIV infection
T2 - results from the D:A:D study(*)
AU - Petoumenos, K
AU - Worm, S
AU - Reiss, P
AU - de Wit, S
AU - d'Arminio Monforte, A
AU - Sabin, C
AU - Friis-Møller, N
AU - Weber, R
AU - Mercie, P
AU - Pradier, C
AU - El-Sadr, W
AU - Kirk, O
AU - Lundgren, J
AU - Law, Mg
AU - D:A:D Study Group
N1 - © 2011 British HIV Association.
PY - 2011
Y1 - 2011
N2 - The aim of the study was to estimate the rates of cardiovascular disease (CVD) events after stopping smoking in patients with HIV infection.
AB - The aim of the study was to estimate the rates of cardiovascular disease (CVD) events after stopping smoking in patients with HIV infection.
KW - Adult
KW - Argentina
KW - CD4 Lymphocyte Count
KW - Cardiovascular Diseases
KW - Cohort Studies
KW - Europe
KW - Female
KW - HIV Infections
KW - Humans
KW - Incidence
KW - Male
KW - Middle Aged
KW - Prospective Studies
KW - Risk Factors
KW - Smoking
KW - Smoking Cessation
KW - United States
U2 - 10.1111/j.1468-1293.2010.00901.x
DO - 10.1111/j.1468-1293.2010.00901.x
M3 - Journal article
C2 - 21251183
VL - 12
SP - 412
EP - 421
JO - Topics in antiviral medicine
JF - Topics in antiviral medicine
SN - 2161-5861
IS - 7
ER -
